| pubmed-article:14960731 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14960731 | lifeskim:mentions | umls-concept:C0443286 | lld:lifeskim |
| pubmed-article:14960731 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:14960731 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:14960731 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:14960731 | lifeskim:mentions | umls-concept:C0207762 | lld:lifeskim |
| pubmed-article:14960731 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:14960731 | pubmed:dateCreated | 2004-4-14 | lld:pubmed |
| pubmed-article:14960731 | pubmed:abstractText | A robust and scalable procedure for the palladium-catalyzed dynamic kinetic asymmetric transformation of 3,4-epoxy-1-butene into (2R)-3-butene-1,2-diol with water as the cosolvent is reported. Examination of the effects of solvent and temperature led to the identification of conditions that permitted use of 0.025 mol % catalyst, providing (2R)-3-butene-1,2-diol in 84% isolated yield and 85% enantiomeric excess. Subsequent Heck reactions with a diverse range of coupling partners are described and the influence of their electronic nature on maintaining the enantiopurity of the diol is discussed. | lld:pubmed |
| pubmed-article:14960731 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14960731 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14960731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14960731 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14960731 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:14960731 | pubmed:issn | 0027-8424 | lld:pubmed |
| pubmed-article:14960731 | pubmed:author | pubmed-author:FoxMartinM | lld:pubmed |
| pubmed-article:14960731 | pubmed:author | pubmed-author:JacksonMarkM | lld:pubmed |
| pubmed-article:14960731 | pubmed:author | pubmed-author:LennonIan CIC | lld:pubmed |
| pubmed-article:14960731 | pubmed:author | pubmed-author:MeekGrahamG | lld:pubmed |
| pubmed-article:14960731 | pubmed:author | pubmed-author:CheesemanNata... | lld:pubmed |
| pubmed-article:14960731 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14960731 | pubmed:day | 13 | lld:pubmed |
| pubmed-article:14960731 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:14960731 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14960731 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14960731 | pubmed:pagination | 5396-9 | lld:pubmed |
| pubmed-article:14960731 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:14960731 | pubmed:meshHeading | pubmed-meshheading:14960731... | lld:pubmed |
| pubmed-article:14960731 | pubmed:meshHeading | pubmed-meshheading:14960731... | lld:pubmed |
| pubmed-article:14960731 | pubmed:meshHeading | pubmed-meshheading:14960731... | lld:pubmed |
| pubmed-article:14960731 | pubmed:meshHeading | pubmed-meshheading:14960731... | lld:pubmed |
| pubmed-article:14960731 | pubmed:meshHeading | pubmed-meshheading:14960731... | lld:pubmed |
| pubmed-article:14960731 | pubmed:meshHeading | pubmed-meshheading:14960731... | lld:pubmed |
| pubmed-article:14960731 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14960731 | pubmed:articleTitle | An efficient, palladium-catalyzed, enantioselective synthesis of (2R)-3-butene-1,2-diol and its use in highly selective Heck reactions. | lld:pubmed |
| pubmed-article:14960731 | pubmed:affiliation | Dowpharma, Chirotech Technology Ltd., Dow Chemical Company, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom. | lld:pubmed |
| pubmed-article:14960731 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14960731 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
